Prof. Dr. Hai-Shu Lin is an associate professor at Shenzhen Technology University. He graduated from Sun Yat-sen University in 1997 and received his PhD from the Department of Pharmacy, National University of Singapore in 2002. He then engaged in postdoctoral research in Singapore, Australia, and France. From 2012 to 2020, he served as an Assistant Professor in the Department of Pharmacy at the National University of Singapore. In January 2021, he joined the School of Pharmacy of Shenzhen University of Technology full-time. He has long been engaged in drug analysis, pharmacokinetics, and anti-inflammatory pharmacology research. In the past ten years, his scientific research has mainly focused on natural derivatives of resveratrol. He has received more than RMB 4 million in scientific research funding. He has published more than 60 research papers in international core academic journals such as the British Journal of Pharmacology, Molecular Nutrition & Food Research, and Rheumatology. He serves as Associate Editor of Frontiers in Pharmacology, editorial board member of the International Journal of Environmental Research and Public Health, and reviewer of more than 80 academic journals.
Research Keywords & Expertise
Bioanalysis
Drug Metabolism
Nutraceuticals
Pharmacokinetics
natural product
resveratrol
Drug delivery and drug...
Anti-inflammatory phar...
Fingerprints
64%
Pharmacokinetics
30%
resveratrol
8%
Nutraceuticals
5%
Drug Metabolism
5%
natural product
5%
Drug delivery and drug targeting
Short Biography
Prof. Dr. Hai-Shu Lin is an associate professor at Shenzhen Technology University. He graduated from Sun Yat-sen University in 1997 and received his PhD from the Department of Pharmacy, National University of Singapore in 2002. He then engaged in postdoctoral research in Singapore, Australia, and France. From 2012 to 2020, he served as an Assistant Professor in the Department of Pharmacy at the National University of Singapore. In January 2021, he joined the School of Pharmacy of Shenzhen University of Technology full-time. He has long been engaged in drug analysis, pharmacokinetics, and anti-inflammatory pharmacology research. In the past ten years, his scientific research has mainly focused on natural derivatives of resveratrol. He has received more than RMB 4 million in scientific research funding. He has published more than 60 research papers in international core academic journals such as the British Journal of Pharmacology, Molecular Nutrition & Food Research, and Rheumatology. He serves as Associate Editor of Frontiers in Pharmacology, editorial board member of the International Journal of Environmental Research and Public Health, and reviewer of more than 80 academic journals.